Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Documentation of Nursing Diagnosis01:10

Documentation of Nursing Diagnosis

1.8K
The nurse documents nursing diagnoses and enters them into the patient record. The identified patient's nursing diagnosis is either written out with a plan of care or entered into the electronic health record.
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters...
1.8K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Detection of Gross Error: The Q Test01:00

Detection of Gross Error: The Q Test

7.1K
When one or more data points appear far from the rest of the data, there is a need to determine whether they are outliers and whether they should be eliminated from the data set to ensure an accurate representation of the measured value. In many cases, outliers arise from gross errors (or human errors) and do not accurately reflect the underlying phenomenon. In some cases, however, these apparent outliers reflect true phenomenological differences. In these cases, we can use statistical methods...
7.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.4K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

2.1K
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
2.1K
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

2.6K
Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
2.6K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration.

Cancer cell·2026
Same author

The SHERPA trial: A phase I study combining SHP2 inhibitor RMC-4630 and ERK inhibitor LY3214996 in patients with KRAS-mutant pancreatic, non-small cell lung and colorectal cancer.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Exploiting immunogenic cell death to promote antitumor immunity.

Trends in immunology·2026
Same author

CLIM-TIME links genetic cancer drivers to immune landscapes.

Cell·2026
Same author

PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

CRISPR knockout screens reveal JUN as the master mediator of resistance to MAPK inhibition in KRAS-mutant pancreatic cancer.

Journal of experimental & clinical cancer research : CR·2026
Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: May 1, 2026

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting
08:05

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Published on: December 12, 2011

30.6K

Es el diagnóstico, estúpido.

René Bernards1

  • 1Division of Molecular Carcinogenesis, Center for Biomedical Genetics and Cancer Genomics Center, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. r.bernards@nki.nl

Cell
|April 8, 2010
PubMed
Resumen
Este resumen es generado por máquina.

El desarrollo de diagnósticos moleculares es crucial para identificar a los pacientes que se benefician de las costosas terapias dirigidas contra el cáncer, abordando el aumento de los costos de tratamiento. Esta discusión explora los desafíos y el potencial de crear biomarcadores efectivos de respuesta a los medicamentos.

Más Videos Relacionados

Digital Handwriting Analysis of Characters in Chinese Patients with Mild Cognitive Impairment
05:58

Digital Handwriting Analysis of Characters in Chinese Patients with Mild Cognitive Impairment

Published on: March 11, 2021

3.8K
Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
10:26

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

2.9K

Videos de Experimentos Relacionados

Last Updated: May 1, 2026

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting
08:05

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Published on: December 12, 2011

30.6K
Digital Handwriting Analysis of Characters in Chinese Patients with Mild Cognitive Impairment
05:58

Digital Handwriting Analysis of Characters in Chinese Patients with Mild Cognitive Impairment

Published on: March 11, 2021

3.8K
Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
10:26

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

2.9K

Área de la Ciencia:

  • Oncología Oncología.
  • Diagnóstico molecular El diagnóstico molecular es el diagnóstico molecular.
  • Desarrollo de Biomarcadores Desarrollo de Biomarcadores

Sus antecedentes:

  • Los crecientes costos del tratamiento del cáncer requieren estrategias rentables.
  • Las terapias dirigidas ofrecen un tratamiento personalizado, pero requieren la selección del paciente.
  • El diagnóstico molecular puede identificar a quienes responden a terapias dirigidas.

Objetivo del estudio:

  • Discutir el desarrollo de diagnósticos moleculares para predecir la respuesta a terapias dirigidas contra el cáncer.
  • Explorar las oportunidades y los obstáculos en la creación de biomarcadores de respuesta a las drogas.

Principales métodos:

  • Revisión de la literatura y análisis de las tendencias actuales en el diagnóstico molecular.
  • Discusión de los procesos de descubrimiento y validación de biomarcadores.
  • Examen de los desafíos en la implementación clínica.

Principales resultados:

  • Los biomarcadores de respuesta a fármacos son esenciales para la medicina personalizada en oncología.
  • Existen oportunidades significativas en el desarrollo de nuevas herramientas de diagnóstico.
  • Los obstáculos incluyen la validación de biomarcadores, obstáculos regulatorios y rentabilidad.

Conclusiones:

  • El diagnóstico molecular es clave para optimizar la eficacia y el costo de la terapia dirigida contra el cáncer.
  • Se necesita más investigación y colaboración para superar los obstáculos al desarrollo.
  • El desarrollo exitoso de biomarcadores mejorará los resultados de los pacientes y reducirá el gasto en atención médica.